66
IRUS TotalDownloads
Altmetric
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression
File | Description | Size | Format | |
---|---|---|---|---|
onc2014428a.pdf | Published version | 3.27 MB | Adobe PDF | View/Open |
Title: | LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression |
Authors: | Mura, M Hopkins, TG Michael, T Abd-Latip, N Weir, J Aboagye, E Mauri, F Jameson, C Sturge, J Gabra, H Bushell, M Willis, AE Curry, E Blagden, SP |
Item Type: | Journal Article |
Abstract: | RNA-binding proteins (RBPs) bind to and post-transcriptionally regulate the stability of mRNAs. La-related protein 1 (LARP1) is a conserved RBP that interacts with poly-A-binding protein and is known to regulate 5′-terminal oligopyrimidine tract (TOP) mRNA translation. Here, we show that LARP1 is complexed to 3000 mRNAs enriched for cancer pathways. A prominent member of the LARP1 interactome is mTOR whose mRNA transcript is stabilized by LARP1. At a functional level, we show that LARP1 promotes cell migration, invasion, anchorage-independent growth and in vivo tumorigenesis. Furthermore, we show that LARP1 expression is elevated in epithelial cancers such as cervical and non-small cell lung cancers, where its expression correlates with disease progression and adverse prognosis, respectively. We therefore conclude that, through the post-transcriptional regulation of genes such as mTOR within cancer pathways, LARP1 contributes to cancer progression. |
Issue Date: | 22-Dec-2014 |
Date of Acceptance: | 21-Oct-2014 |
URI: | http://hdl.handle.net/10044/1/43636 |
DOI: | https://dx.doi.org/10.1038/onc.2014.428 |
ISSN: | 1476-5594 |
Publisher: | Nature Publishing Group |
Start Page: | 5025 |
End Page: | 5036 |
Journal / Book Title: | Oncogene |
Volume: | 34 |
Copyright Statement: | © 2015 Macmillan Publishers Limited. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
Sponsor/Funder: | GlaxoSmithKline Services Unlimited Wellbeing of Women |
Funder's Grant Number: | COL011953 RG1319 |
Keywords: | Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology Cell Biology Genetics & Heredity MESSENGER-RNA STABILITY GENE-EXPRESSION CERVICAL-CANCER EARLY-STAGE BINDING PROTEINS MAMMALIAN-CELLS TRANSLATION TARGET DECAY SPECIMENS Animals Autoantigens Disease Progression Female Humans Mice Mice, Inbred BALB C Neoplasm Invasiveness Neoplasm Metastasis Neoplasms RNA Processing, Post-Transcriptional RNA, Messenger Ribonucleoproteins TOR Serine-Threonine Kinases Oncology & Carcinogenesis 1112 Oncology And Carcinogenesis 1103 Clinical Sciences |
Publication Status: | Published |
Appears in Collections: | Department of Surgery and Cancer |